HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 106 filers reported holding HERON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,117,000 | -68.1% | 691,400 | -36.1% | 1.39% | -57.3% |
| Q4 2019 | $25,407,000 | +25.9% | 1,081,159 | -0.9% | 3.25% | +6.5% |
| Q3 2019 | $20,186,000 | -1.2% | 1,091,110 | -0.7% | 3.05% | +7.6% |
| Q2 2019 | $20,425,000 | -24.9% | 1,098,723 | -1.3% | 2.84% | -19.8% |
| Q1 2019 | $27,201,000 | +27.1% | 1,112,966 | +34.9% | 3.54% | +3.6% |
| Q4 2018 | $21,407,000 | -18.8% | 825,269 | -0.9% | 3.41% | -19.8% |
| Q3 2018 | $26,364,000 | -18.9% | 833,001 | -0.4% | 4.25% | -15.9% |
| Q2 2018 | $32,507,000 | +148.9% | 836,737 | +76.8% | 5.06% | +76.5% |
| Q1 2018 | $13,062,000 | +74.4% | 473,275 | +14.4% | 2.87% | +39.7% |
| Q4 2017 | $7,488,000 | +17.8% | 413,721 | +5.1% | 2.05% | +2.0% |
| Q3 2017 | $6,355,000 | +24.9% | 393,505 | +7.1% | 2.01% | +17.9% |
| Q2 2017 | $5,088,000 | -6.7% | 367,390 | +1.0% | 1.71% | -18.1% |
| Q1 2017 | $5,455,000 | – | 363,689 | – | 2.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |